Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,226
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Location: Palo Alto CA, Cerritos CA, Anaheim CA, Spokane WA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05254743
Phase3, Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Redwood City CA, Bakersfield CA, Ventura CA,
Location: Redwood City CA, Newport Beach CA, La Jolla CA,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 18+
Code: NCT05059444
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Walnut Creek CA, Dublin CA, Chula Vista CA, Tempe AZ,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase2, Recruiting
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
for
Catheter-Related Infections
Location: Palo Alto CA, Phoenix AZ, Fort Worth TX, Birmingham AL,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 0 - 17
Code: NCT06714864
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Walnut Creek CA, Culver City CA, Bellflower CA,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07172516
Phase3, Recruiting
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
for
Migraine
Location: Walnut Creek CA
Sponsor: Aspeya, Inc.
Sex: All
Age: 18 - 65
Code: NCT07646613
Phase2, Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Location: Stanford CA, Los Angeles CA, La Jolla CA, Seattle WA,
Sponsor: XVIVO Perfusion
Sex: All
Age: 18+
Code: NCT06895070
Recruiting
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Stanford CA, Los Angeles CA, Chino CA, Philadelphia PA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06963021
Phase3, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Walnut Creek CA, Reno NV, West Hills CA, Encino CA,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
for
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Location: Walnut Creek CA, San Diego CA, Edmonton, St Louis MO,
Sponsor: Pharvaris Netherlands B.V.
Sex: All
Age: 18+
Code: NCT07266805
Phase3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2